Cambridge Investment Research Advisors, Inc. Emergent Bio Solutions Inc. Transaction History

Cambridge Investment Research Advisors, Inc.

  • $29.4 Billion
  • Q3 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Aug 10, 2021
SELL
$56.61 - $80.46 $232,101 - $329,886
-4,100 Closed
0 $0
Q1 2021

May 07, 2021
BUY
$86.23 - $125.19 $5,949 - $8,638
69 Added 1.71%
4,100 $380,000
Q4 2020

Feb 04, 2021
SELL
$79.17 - $111.47 $5,700 - $8,025
-72 Reduced 1.75%
4,031 $361,000
Q3 2020

Oct 29, 2020
BUY
$81.91 - $134.94 $31,535 - $51,951
385 Added 10.36%
4,103 $423,000
Q2 2020

Jul 27, 2020
BUY
$54.33 - $89.52 $201,998 - $332,835
3,718 New
3,718 $294,000

Others Institutions Holding EBS

# of Institutions
160
Shares Held
33.8M
Call Options Held
453K
Put Options Held
931K
View Full List

About Emergent BioSolutions Inc.

EBS Quotes by TradingView
  • Ticker EBS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 49,861,500
  • Market Cap $438M
  • Description
  • Emergent BioSolutions Inc., a life sciences company, focuses on the provision of preparedness and response solutions that address accidental, deliberate, and naturally occurring public health threats (PHTs) in the United States. The company's products address PHTs, which include chemical, biological, radiological, nuclear, and explosives; emergi...
More about EBS
Track This Portfolio

Track Cambridge Investment Research Advisors, Inc. Portfolio

Follow Cambridge Investment Research Advisors, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cambridge Investment Research Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Cambridge Investment Research Advisors, Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email